Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 867 of 6351
-
AI app aims to catch deadly skin cancer early in rare disease patients
Diagnosis OngoingIn this study, an artificial intelligence model to detect squamous cell carcinomas (SCC) on photos of recessive dystrophic epidermolysis bullosa (RDEB) skin is developed. The ultimate goal is to integrate this model into an app for patients and physicians, to help detect SCCs in …
Sponsor: Northwestern University • Aim: Diagnosis
Last updated Jun 27, 2026 09:01 UTC
-
Can AI catch the leading cause of blindness before It's too late?
Diagnosis Recruiting nowThe increasing prevalence of diabetes mellitus represents a major health problem, especially since around 40% of diabetic patients develop diabetic retinopathy, which severely impairs vision and can lead to blindness. This development could be prevented by annual check-ups and ti…
Sponsor: West German Center of Diabetes and Health • Aim: Diagnosis
Last updated Aug 12, 2026 00:00 UTC
-
Nose spray could block COVID spread in homes
Prevention CompletedCoronavirus-induced disease 2019 (COVID-19) is an infection caused by a virus whose full name is severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This is a new and rapidly-spreading infectious disease which carries a significant risk of death, has brought massive eco…
Phase 2/3 • Sponsor: Murdoch Childrens Research Institute • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
New shot could tame teen eczema
Disease control CompletedThe primary objective of this study is to describe the safety and tolerability of rocatinlimab in adolescents with moderate-to-severe AD.
Phase 3 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New pill could ease severe asthma attacks
Disease control OngoingThe purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma to evaluate improvements in lung function, asthma control, and quality of life. In addition, the study will further evaluate the safe…
Phase 3 • Sponsor: Areteia Therapeutics • Aim: Disease control
Last updated Jun 26, 2026 14:18 UTC
-
Could a COVID-19 pill shield heart surgery patients from complications?
Prevention CompletedProphylactic effect of nirmatrelvir/ritonavir and ursodeoxycholic acid on reducing complications after cardiac surgery during covid-19 pandemics (the pep trial) is a multicenter, randomized controlled trial. The aim of the pep trial is to investigate whether prophylactic use of n…
Phase 4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Prevention
Last updated Aug 27, 2026 00:00 UTC
-
Blood test may revolutionize cancer treatment selection
Knowledge-focused Recruiting nowOverall, this project has three main goals: first, to ascertain the feasibility of the approach and identify whether liquid biopsies can detect actionable mutations that can be utilized to generate precision oncology treatment recommendations. Second, the investigators will inves…
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Can a pill boost the immune system to fight Hard-to-Treat cancers?
Disease control Recruiting nowThe goal of this clinical trial is to learn if the OATD-02 administration (orally) in monotherapy is safe and has the pharmacodynamic potential to restore and enhance tumour responses to immunotherapy through increased arginine levels or intrinsic anti-tumour activity in particip…
Phase 1 • Sponsor: Molecure S.A. • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
New drug combo aims to boost lymphoma treatment
Disease control OngoingThis phase I/II trial tests the safety of tafasitamab, retifanlimab, and rituximab (TRR) as a prephase treatment and in combination with standard therapy consisting off cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or polatuzumab vedotin, cyclophosphamide, dox…
Phase 1/2 • Sponsor: University of Washington • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New program aims to cut teen suicide events in half
Disease control Recruiting nowThis protocol will test the effectiveness of an intervention, iCHART (integrated Care to Help At-Risk Teens) and facilitate recruitment for other studies in the larger ETUDES Center grant, which are focused on treatment development for target risk factors for suicidal behavior, s…
Sponsor: University of Pittsburgh • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New combo aims to shrink lymphoma tumors with less chemo
Disease control OngoingThis study is planned as a single arm clinical trial of tazemetostat in combination with bendamustine and rituximab with both a phase I and phase II component. All patients will receive tazemetostat twice daily on days 1-28 in combination with bendamustine 90 mg/m2 IV on days 1 a…
Phase 1/2 • Sponsor: Vaishalee Kenkre • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Gene-Guided radiation aims to sharpen breast cancer treatment
Disease control Recruiting nowThe purpose of the study is to determine the feasibility of genomically guided radiation therapy (RT) in people with triple negative (HER2 negative, hormone receptor negative) breast cancer undergoing breast conservation therapy.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New drug duo offers hope for Tough-to-Treat lymphoma
Disease control Recruiting nowTo learn if the combination of pirtobrutinib (also called LOXO-305) and venetoclax can help to control mantle cell lymphoma (MCL) that is relapsed (has come back) or refractory (has not responded to therapy).
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Spinal zaps may restore hand function in paralyzed veterans
Disease control Recruiting nowIn support of the long-term goal of developing new strategies to increase limb function after SCI, the objectives of this proposal are to: 1) Examine the behavioral and physiological effects of TESS on upper-limb muscles after cervical SCI; and 2) Maximize the recovery of reachin…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Radiation plus immunotherapy before lung surgery shows promise in early trial
Disease control OngoingAn open label, randomized study of neoadjuvant nivolumab and chemotherapy, with or without sub-ablative stereotactic body radiation therapy, for resectable stage IIA to IIIB non-small cell lung cancer
Phase 2 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Deeper stroke Check-Ups could slash repeat risk
Disease control By invitation onlyAnnually, about 4000 Swedes suffer a recurrent stroke, and for many, their lives change dramatically. To prevent recurring strokes, knowledge about the individual's risk of recurrence is needed to tailor an effective preventive medical treatment. The purpose of the SALSA study i…
Sponsor: Region Stockholm • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Heart pouch closure during surgery may slash stroke risk
Prevention OngoingThis trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects …
Sponsor: AtriCure, Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New drug combo aims to boost immune attack on returning brain tumors
Disease control Recruiting nowThis phase II trial tests the safety and side effects of efineptakin alfa and pembrolizumab in treating patients with glioblastoma that has come back (recurrent). Efineptakin alfa is an immunotherapy drug that works by helping the immune system fight tumor cells. Immunotherapy wi…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New monthly shot could simplify schizophrenia treatment
Disease control CompletedThe primary objective of this study is to evaluate the efficacy of TV-44749 in adult participants with schizophrenia. A key secondary objective is to further evaluate the efficacy of TV-44749 based on additional parameters in adult participants with schizophrenia. A secondary o…
Phase 3 • Sponsor: Teva Branded Pharmaceutical Products R&D LLC • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can cord blood platelets soothe a painful skin condition?
Disease control CompletedVulvar lichen Sclerosus (VLS) is a cutaneous-mucosal dermatosis that causes in the adult female vulvar itching and burning due to scratching abrasions. Dyspareunia is often associated . The areas most affected are the labia minora, the periclitoral area, the navicular dimple, and…
Phase 1/2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC